The recently proposed loss-of-function phenotype associated with FAD-PS1 raises a question about the possibility of extending this pathogenic hypothesis to FAD-PS2-linked cases, given the overlapping phenotype among AD patients carrying PSEN1 or PSEN2 mutations [5]. The gene discussed is PSEN1; the disease is Alzheimer disease.